Zeltiq Aesthetics Inc (ZLTQ) 34.48 $ZLTQ
ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2014 Financial Results to Be Held on March 3, 2015
Marketwired - Tue Feb 10, 3:06PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2014 financial results on Tuesday, March 3, 2015 after the market close.
ZLTQ: 34.48 (+0.28)
Zeltiq's CoolSculpting cleared for lower temps
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 10:28AM CST
ZLTQ: 34.48 (+0.28)
Interesting ZLTQ Put And Call Options For March 20th
DividendChannel.com - Thu Jan 29, 9:53AM CST
Investors in ZELTIQ Aesthetics Inc. saw new options become available this week, for the March 20th expiration.
ZLTQ: 34.48 (+0.28)
ZELTIQ(R) Receives FDA Clearance to Perform CoolSculpting(R) Procedure at Lower Temperatures for Shorter Treatment Times
Business Wire - Thu Jan 29, 7:30AM CST
--Company Will Launch New CoolSmooth PRO(TM) Applicator in Conjunction with This Clearance
ZLTQ: 34.48 (+0.28)
Will ZELTIQ (ZLTQ) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 8:18AM CST
Will ZELTIQ (ZLTQ) Continue to Surge Higher?
ZLTQ: 34.48 (+0.28)
Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 1:40PM CST
Notably, in three of the past four quarters, Mead Johnson's (MJN) earnings have outpaced the Zacks Consensus Estimate with an average beat of 3.07%.
ZLTQ: 34.48 (+0.28), MJN: 101.89 (+2.32), BCR: 175.38 (+0.50), HOLX: 30.46 (+0.21)
CoolSculpting(R) Procedure Named "Best Fat-Reducing Treatment" by NewBeauty(R) Magazine
Marketwired - Tue Jan 27, 7:01AM CST
The CoolSculpting(R) procedure, a non-invasive procedure that uses cooling technology to noticeably eliminate fat without surgery was awarded "Best Fat-Reducing Treatment" by NewBeauty(R) magazine, the definitive authority on all things beauty. Voted as the "hottest choice" by a panel of experts, editors and readers, the CoolSculpting procedure was a recipient of the magazine's fifth annual Beauty Choice Awards highlighted in its Winter 2015 issue.
ZLTQ: 34.48 (+0.28)
Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 1:00PM CST
Illumina (ILMN) now expects adjusted earnings per share for full year 2014 slightly above the top end of its previously announced guidance range of $2.63???$2.65.
ZLTQ: 34.48 (+0.28), BCR: 175.38 (+0.50), ILMN: 198.54 (+1.81), HOLX: 30.46 (+0.21)
Zeltiq Aesthetics Turns A Profit By Reducing Fat
at Investor's Business Daily - Wed Jan 21, 4:28PM CST
After a rocky debut in October 2011, Zeltiq Aesthetics (ZLTQ) is near a new high, riding its 10-week moving average higher. After years of losses, the fat-reduction company has reported two profitable quarters and is expected to report a profit this...
ZLTQ: 34.48 (+0.28)
Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 11:20AM CST
Baxter International Inc. (BAX) expects the PHOXILLUM phosphate-containing solutions to be available in the U.S. from the second quarter of 2015.
ICUI: 88.98 (+0.42), ZLTQ: 34.48 (+0.28), BAX: 70.39 (+0.31), VASC: 26.44 (+0.79)
New Year, New You, New Findings -- New Survey Reveals What Women Expect to Gain by Keeping New Year's Resolution to "Lose the Fat"
Marketwired - Wed Jan 21, 7:02AM CST
There is so much to gain from losing fat, it is no wonder that more than 1 in 2 (51%) women put "losing fat" on their New Year's resolution list this year. According to a new survey conducted by Kelton Research for the CoolSculpting(R) procedure, women who planned to make the resolution to lose fat feel they would reap benefits beyond physical appearance, including improved physical health (75%), confidence (65%), and emotional health (55%).
ZLTQ: 34.48 (+0.28)
Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 11:20AM CST
ResMed (RMD) expects to launch the AirCurve 10 platform in key global markets in the coming quarters of fiscal 2015.
ZLTQ: 34.48 (+0.28), RMD: 66.25 (+0.79), ILMN: 198.54 (+1.81), HOLX: 30.46 (+0.21)
ZELTIQ Aesthetics (ZLTQ) Catches Eye: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 7:30AM CST
ZELTIQ Aesthetics, Inc. (ZLTQ) was a big mover last session, as the company saw its shares rise over 6% on the day.
ICUI: 88.98 (+0.42), ZLTQ: 34.48 (+0.28)
Zeltiq, Stryker, St. Jude Move On Prelim Q4 Reports
at Investor's Business Daily - Wed Jan 14, 11:48AM CST
Medical device stocks were moving Wednesday as three high-rated players all released preliminary Q4 numbers at the JPMorgan Healthcare Conference. Zeltiq Aesthetics (ZLTQ), a startup that sells a system for whittling down fat bulges, said late...
JNJ: 99.62 (+1.18), ZLTQ: 34.48 (+0.28), STJ: 67.48 (+0.65), SYK: 94.51 (+1.14)
ZELTIQ Aesthetics (ZLTQ) Is Strong On High Volume Today
at The Street - Wed Jan 14, 9:10AM CST
Trade-Ideas LLC identified ZELTIQ Aesthetics (ZLTQ) as a strong on high relative volume candidate
ZLTQ: 34.48 (+0.28)
Technical Commentary on Health Care Equipment Stocks - Hologic, St. Jude Medical, Covidien, Wright Medical, and Zeltiq Aesthetics
PR Newswire - Wed Jan 14, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Hologic Inc. (NASDAQ: HOLX), St Jude Medical Inc. (NYSE: STJ), Covidien PLC (NYSE: COV), Wright Medical Group Inc. (NASDAQ: WMGI), and Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, January 13, 2015, the NASDAQ Composite ended at 4,661.50, down 0.07%, the Dow Jones Industrial Average edged 0.15% lower, to finish the day at 17,613.68, and the S&P 500 closed at 2,023.03, down 0.26%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 808.73, down 0.49%, while the index has advanced 13.71% in the last three months. Register for your complimentary reports on these five stocks at:
ZLTQ: 34.48 (+0.28), WMGI: 25.68 (+0.17), COV: 106.71 (-1.36), STJ: 67.48 (+0.65), WMGIZ: 4.20 (-0.05), HOLX: 30.46 (+0.21)
ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference
Marketwired - Tue Jan 13, 7:11PM CST
ZELTIQ(R), (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, CoolSculpting(R), will present at the J.P. Morgan 33rd Annual Healthcare Conference tomorrow, Wednesday, January 14, 2015. President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PT / 10:30 a.m. ET at the Westin St. Francis Hotel in San Francisco. A copy of ZELTIQ's investor presentation is available on the investor relations section of ZELTIQ's web site, at www.coolsculpting.com.
ZLTQ: 34.48 (+0.28), JPM: 59.67 (+0.10)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 4:42PM CST
TSLA: 203.77 (+0.89), INNL: 8.50 (unch), ZLTQ: 34.48 (+0.28), ASPS: 22.32 (+0.09), PRGS: 26.67 (-0.16), GME: 37.35 (+0.10), VMI: 124.24 (+1.02), CHOC: 42.40 (unch), CZR: 10.78 (+0.18), NOK: 8.02 (+0.05)
Zeltiq reports preliminary revenues and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 3:44PM CST
ZLTQ: 34.48 (+0.28)
ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2014 Revenue
Marketwired - Tue Jan 13, 3:01PM CST
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 34.48 (+0.28)
ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2014 Financial Results to Be Held on March 3, 2015
Marketwired - Tue Feb 10, 3:06PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2014 financial results on Tuesday, March 3, 2015 after the market close.
ZLTQ: 34.48 (+0.28)
Zeltiq's CoolSculpting cleared for lower temps
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 10:28AM CST
ZLTQ: 34.48 (+0.28)
Interesting ZLTQ Put And Call Options For March 20th
DividendChannel.com - Thu Jan 29, 9:53AM CST
Investors in ZELTIQ Aesthetics Inc. saw new options become available this week, for the March 20th expiration.
ZLTQ: 34.48 (+0.28)
ZELTIQ(R) Receives FDA Clearance to Perform CoolSculpting(R) Procedure at Lower Temperatures for Shorter Treatment Times
Business Wire - Thu Jan 29, 7:30AM CST
--Company Will Launch New CoolSmooth PRO(TM) Applicator in Conjunction with This Clearance
ZLTQ: 34.48 (+0.28)
Will ZELTIQ (ZLTQ) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 8:18AM CST
Will ZELTIQ (ZLTQ) Continue to Surge Higher?
ZLTQ: 34.48 (+0.28)
Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 27, 1:40PM CST
Notably, in three of the past four quarters, Mead Johnson's (MJN) earnings have outpaced the Zacks Consensus Estimate with an average beat of 3.07%.
ZLTQ: 34.48 (+0.28), MJN: 101.89 (+2.32), BCR: 175.38 (+0.50), HOLX: 30.46 (+0.21)
CoolSculpting(R) Procedure Named "Best Fat-Reducing Treatment" by NewBeauty(R) Magazine
Marketwired - Tue Jan 27, 7:01AM CST
The CoolSculpting(R) procedure, a non-invasive procedure that uses cooling technology to noticeably eliminate fat without surgery was awarded "Best Fat-Reducing Treatment" by NewBeauty(R) magazine, the definitive authority on all things beauty. Voted as the "hottest choice" by a panel of experts, editors and readers, the CoolSculpting procedure was a recipient of the magazine's fifth annual Beauty Choice Awards highlighted in its Winter 2015 issue.
ZLTQ: 34.48 (+0.28)
Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 1:00PM CST
Illumina (ILMN) now expects adjusted earnings per share for full year 2014 slightly above the top end of its previously announced guidance range of $2.63???$2.65.
ZLTQ: 34.48 (+0.28), BCR: 175.38 (+0.50), ILMN: 198.54 (+1.81), HOLX: 30.46 (+0.21)
Zeltiq Aesthetics Turns A Profit By Reducing Fat
at Investor's Business Daily - Wed Jan 21, 4:28PM CST
After a rocky debut in October 2011, Zeltiq Aesthetics (ZLTQ) is near a new high, riding its 10-week moving average higher. After years of losses, the fat-reduction company has reported two profitable quarters and is expected to report a profit this...
ZLTQ: 34.48 (+0.28)
Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 11:20AM CST
Baxter International Inc. (BAX) expects the PHOXILLUM phosphate-containing solutions to be available in the U.S. from the second quarter of 2015.
ICUI: 88.98 (+0.42), ZLTQ: 34.48 (+0.28), BAX: 70.39 (+0.31), VASC: 26.44 (+0.79)
New Year, New You, New Findings -- New Survey Reveals What Women Expect to Gain by Keeping New Year's Resolution to "Lose the Fat"
Marketwired - Wed Jan 21, 7:02AM CST
There is so much to gain from losing fat, it is no wonder that more than 1 in 2 (51%) women put "losing fat" on their New Year's resolution list this year. According to a new survey conducted by Kelton Research for the CoolSculpting(R) procedure, women who planned to make the resolution to lose fat feel they would reap benefits beyond physical appearance, including improved physical health (75%), confidence (65%), and emotional health (55%).
ZLTQ: 34.48 (+0.28)
Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 11:20AM CST
ResMed (RMD) expects to launch the AirCurve 10 platform in key global markets in the coming quarters of fiscal 2015.
ZLTQ: 34.48 (+0.28), RMD: 66.25 (+0.79), ILMN: 198.54 (+1.81), HOLX: 30.46 (+0.21)
ZELTIQ Aesthetics (ZLTQ) Catches Eye: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 7:30AM CST
ZELTIQ Aesthetics, Inc. (ZLTQ) was a big mover last session, as the company saw its shares rise over 6% on the day.
ICUI: 88.98 (+0.42), ZLTQ: 34.48 (+0.28)
Zeltiq, Stryker, St. Jude Move On Prelim Q4 Reports
at Investor's Business Daily - Wed Jan 14, 11:48AM CST
Medical device stocks were moving Wednesday as three high-rated players all released preliminary Q4 numbers at the JPMorgan Healthcare Conference. Zeltiq Aesthetics (ZLTQ), a startup that sells a system for whittling down fat bulges, said late...
JNJ: 99.62 (+1.18), ZLTQ: 34.48 (+0.28), STJ: 67.48 (+0.65), SYK: 94.51 (+1.14)
ZELTIQ Aesthetics (ZLTQ) Is Strong On High Volume Today
at The Street - Wed Jan 14, 9:10AM CST
Trade-Ideas LLC identified ZELTIQ Aesthetics (ZLTQ) as a strong on high relative volume candidate
ZLTQ: 34.48 (+0.28)
Technical Commentary on Health Care Equipment Stocks - Hologic, St. Jude Medical, Covidien, Wright Medical, and Zeltiq Aesthetics
PR Newswire - Wed Jan 14, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Hologic Inc. (NASDAQ: HOLX), St Jude Medical Inc. (NYSE: STJ), Covidien PLC (NYSE: COV), Wright Medical Group Inc. (NASDAQ: WMGI), and Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Tuesday, January 13, 2015, the NASDAQ Composite ended at 4,661.50, down 0.07%, the Dow Jones Industrial Average edged 0.15% lower, to finish the day at 17,613.68, and the S&P 500 closed at 2,023.03, down 0.26%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 808.73, down 0.49%, while the index has advanced 13.71% in the last three months. Register for your complimentary reports on these five stocks at:
ZLTQ: 34.48 (+0.28), WMGI: 25.68 (+0.17), COV: 106.71 (-1.36), STJ: 67.48 (+0.65), WMGIZ: 4.20 (-0.05), HOLX: 30.46 (+0.21)
ZELTIQ to Present at J.P. Morgan 33rd Annual Healthcare Conference
Marketwired - Tue Jan 13, 7:11PM CST
ZELTIQ(R), (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, CoolSculpting(R), will present at the J.P. Morgan 33rd Annual Healthcare Conference tomorrow, Wednesday, January 14, 2015. President and Chief Executive Officer, Mark Foley, will present at 7:30 a.m. PT / 10:30 a.m. ET at the Westin St. Francis Hotel in San Francisco. A copy of ZELTIQ's investor presentation is available on the investor relations section of ZELTIQ's web site, at www.coolsculpting.com.
ZLTQ: 34.48 (+0.28), JPM: 59.67 (+0.10)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 4:42PM CST
TSLA: 203.77 (+0.89), INNL: 8.50 (unch), ZLTQ: 34.48 (+0.28), ASPS: 22.32 (+0.09), PRGS: 26.67 (-0.16), GME: 37.35 (+0.10), VMI: 124.24 (+1.02), CHOC: 42.40 (unch), CZR: 10.78 (+0.18), NOK: 8.02 (+0.05)
Zeltiq reports preliminary revenues and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Tue Jan 13, 3:44PM CST
ZLTQ: 34.48 (+0.28)
ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2014 Revenue
Marketwired - Tue Jan 13, 3:01PM CST
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 34.48 (+0.28)
